Skip to Main Content

Paper Details

Nadir Prostate-specific Antigen as an Independent Predictor of Survival Outcomes: A Post Hoc Analysis of the PROSPER Randomized Clinical Trial.
J Urol
3
2023
Author NameAffiliation
Maha HussainRobert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine
Cora N SternbergEnglander Institute for Precision Medicine, Meyer Cancer Center
Eleni EfstathiouMD Anderson Cancer Center
Fred SaadUniversity of Montreal Hospital Center
  • 1 - 4

Datasets